Sahin, I. H., Hsieh, R. W., Kasi, P. M., Gorantla, V., Cohen, S. A., Rhee, J. C., Safyan, R. A., Tatsuoka, C., Chiorean, E. G., Boland, P. M., Kim, R. D., Tejani, M. A., Saeed, A. (2025). Combining low-dose regorafenib with pembrolizumab as a front-line therapy for patients with MSI-H colorectal cancer: REGPEM-CRC-01.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps3643